Glaukos Corporation logo

Senior Scientist - Downstream Process Development

Glaukos Corporation

Aliso Viejo, CAOnsitePosted 2 days ago$97,900 - $122,400/year
Full TimeSenior LevelManufacturing & CMCMedical Device
Original posting ↗

Summary

Requires a bachelor's degree in biology, chemistry, biotechnology, biochemistry, or a related field, with 7+ years of experience or an advanced (Master's degree or Ph.D.) in a similar field with 3 – 5 years of experience; experience in GMP manufacturing environment is desirable. CDMO experience is preferred. Microbial, mammalian, and/or cell or gene therapy experience preferred.

Job description

Detailed Responsibilities

  • Cross Functional: Support the CDMO/Glaukos manufacturing, quality, R&D, supply chain, and regulatory teams
  • Technology Transfer: Scale up processes from R&D or pilot scale to GMP manufacture and ultimately commercial-ready manufacturing, employing phase-appropriate controls
  • Manufacturing Support: Provide technical support (Person in the Plant - PIP) during campaigns and troubleshooting equipment, raw materials, suppliers, or investigations
  • Process Monitoring & Optimization: Analyze manufacturing data to ensure processes remain in a state of control, using statistical tools to drive continuous improvement
  • Documentation: Author and/or review process trending, technical protocols and reports, quality events, batch records, and regulatory filings
  • Technical Expertise: Expertise in aseptic processing, purification unit operations (e.g., depth filtration, chromatography, ultrafiltration, and diafiltration), data analysis, and regulatory knowledge
  • Production experience with microbial cultures, mammalian cultures
  • Supporting harvest through purified bulk drug substance manufacturing
  • Additional Skills: Support CDMO selection and audits
  • Experience with cell culture and gene therapy is a plus
  • Strong foundational knowledge of upstream process development including process optimization skills are desirable

Qualifications

Requires a bachelor's degree in biology, chemistry, biotechnology, biochemistry, or a related field, with 7+ years of experience or an advanced (Master's degree or Ph.D.) in a similar field with 3 – 5 years of experience; experience in GMP manufacturing environment is desirable. CDMO experience is preferred. Microbial, mammalian, and/or cell or gene therapy experience preferred.

Requirements

  • Bachelor's degree in biology, chemistry, biotechnology, biochemistry, or a related field with 7+ years of experience, or advanced degree (Master's or Ph.D.) with 3-5 years of experience
  • Expertise in aseptic processing
  • Expertise in purification unit operations (depth filtration, chromatography, ultrafiltration, diafiltration)
  • Data analysis skills
  • Regulatory knowledge
  • Production experience with microbial cultures
  • Production experience with mammalian cultures
  • Experience supporting harvest through purified bulk drug substance manufacturing
  • GMP manufacturing environment experience (desirable)
  • CDMO experience (preferred)
  • Microbial, mammalian, and/or cell or gene therapy experience (preferred)
  • Experience with cell culture and gene therapy (plus)
  • Strong foundational knowledge of upstream process development including process optimization (desirable)

Company overview

Glaukos Corporation is a pioneering medical technology company focused on transforming the treatment of glaucoma, one of the world's leading causes of irreversible blindness. Founded in 1998 and headquartered in San Clemente, California, Glaukos revolutionized glaucoma treatment with the introduction of micro-invasive glaucoma surgery (MIGS) through its iStent technology, which became the first MIGS device to receive FDA approval. The company specializes in developing innovative, minimally invasive ophthalmic medical devices and sustained pharmaceutical therapies designed to improve clinical outcomes for patients with glaucoma and other eye diseases. Glaukos' product portfolio includes the iStent family of trabecular micro-bypass stents, the iStent inject W device, and various pharmaceutical candidates in development. As a leader in the MIGS market, Glaukos continues to advance its pipeline of novel technologies aimed at addressing the full spectrum of glaucoma disease progression while maintaining its commitment to improving patient quality of life through less invasive treatment options.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.